Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ANVS - INmune Bio: Underfollowed AD Player With Very Bullish August Momentum

ANVS - INmune Bio: Underfollowed AD Player With Very Bullish August Momentum

Annovis Bio Inc.
  • With XPro1595, it has a disease-modifying drug candidate that has already shown to consistently decrease multiple biomarkers of neuroinflammation;
  • The test is now how this affects biomarkers of neurodegeneration and AD; readout to be expected in August 2021;
  • INmune Bio is not an AD pure play, and its other drug candidates hold equal promise;
  • The size of the addressable AD market is enormous, which is only one of the multiple markets INmune Bio is targeting.

For further details see:

INmune Bio: Underfollowed AD Player With Very Bullish August Momentum
Stock Information
Company Name: Annovis Bio Inc.
Stock Symbol: ANVS
Market: OTC
Website: annovisbio.com
Menu
ANVS ANVS Quote ANVS Short ANVS News ANVS Articles ANVS Message Board
Get ANVS Alerts

News, Short Squeeze, Breakout and More Instantly...